68499-56-9

Basic information

• Product Name: 1,3,4,6-tetra-O-acetyl-2-chloroacetamido-2-deoxy-beta-glucopyranose
• Synonyms: 1,3,4,6-tetra-O-acetyl-2-chloroacetamido-2-deoxy-beta-glucopyranose
• CAS NO: 68499-56-9
• Molecular Formula: C₁₆H₂₂ClNO₁₀
• Molecular Weight: 423.7996
• Mol File: 68499-56-9.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 554°Cat760mmHg
• Flash Point: 288.9°C
• Appearance: /
• Density: 1.36g/cm³
• Vapor Pressure: 2.58E-12mmHg at 25°C
• Refractive Index: 1.502
• CAS DataBase Reference: 1,3,4,6-tetra-O-acetyl-2-chloroacetamido-2-deoxy-beta-glucopyranose(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3,4,6-tetra-O-acetyl-2-chloroacetamido-2-deoxy-beta-glucopyranose(68499-56-9)
• EPA Substance Registry System: 1,3,4,6-tetra-O-acetyl-2-chloroacetamido-2-deoxy-beta-glucopyranose(68499-56-9)

Safety Data

• Hazardous Substances Data: 68499-56-9(Hazardous Substances Data)

Usage

InChI:InChI=1/C16H22ClNO10/c1-7(19)24-6-11-14(25-8(2)20)15(26-9(3)21)13(18-12(23)5-17)16(28-11)27-10(4)22/h11,13-16H,5-6H2,1-4H3,(H,18,23)/t11-,13-,14-,15-,16-/m1/s1

Upstream product

• 17460-45-6 tetra-acetyl glucosamine 
• 5432-46-2 1,3,4,6-tetra-O-acetyl-D-glucosamine hydrochloride 
• 79-04-9 chloroacetyl chloride 
• 541-88-8 Chloroacetic anhydride 
• 7597-81-1 1,3,4,6-tetra-O-acetyl-2-deoxy-2-(4-methoxybenzylidene)amino-β-D-glucopyranose 
• 79-11-8 chloroacetic acid 
• 1078691-95-8 (+)-D-glucosamine hydrochloride 
• 51471-40-0 6-(hydroxymethyl)-3-[4-methoxybenzylideneamino]tetrahydropyran-2,4,5-triol 
• 51471-40-0 2--2-deoxy-D-glucopyranose 

Downstream Products

• 129437-65-6 allyl O-(3,4,6-tri-O-acetyl-2-chloroacetamido-2-deoxy-β-D-glucopyranosyl)-(1->4)-2,4,6-tri-O-benzyl-α-D-galactopyranoside 
• 72333-25-6 allyl 3,4,6-tri-O-acetyl-2-(chloroacetamido)-2-deoxy-β-D-glucopyranoside 
• 129437-68-9 allyl O-(3,4,6-tri-O-acetyl-2-chloroacetamido-2-deoxy-α-D-glucopyranosyl)-(1->4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 129437-72-5 allyl O-(3,4,6-tri-O-acetyl-2-chloroacetamido-2-deoxy-β-D-glucopyranosyl)-(1->4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 129437-66-7 methyl O-(3,4,6-tri-O-acetyl-2-chloroacetamido-2-deoxy-β-D-glucopyranosyl)-(1->4)-2,4,6-tri-O-benzyl-α-D-glucopyranoside 
• 13347-90-5 benzyl 3,4,6-tri-O-acetyl-2-(chloroacetylylamino)-2-deoxy-β-D-glucopyranoside 
• 129437-64-5 methyl O-(3,4,6-tri-O-acetyl-2-chloroacetamido-2-deoxy-β-D-glucopyranosyl)-(1->3)-2,4,6-tri-O-benzyl-α-D-galactopyranoside 
• 134040-56-5 Allyl 4-O-benzyl-2-deoxy-6-O-(3,4,6-tri-O-acetyl-2-chloroacetylamino-2-deoxy-β-D-glucopyranosyl)-3-O-(2,2,2-trichloro-tert-butoxycarbonyl)-2-(2,2,2-trichloroethoxycarbonylamino)-α-D-glucopyranoside 
• 103559-33-7 Allyl 4-O-benzyl-6-O-(3,4,6-tri-O-acetyl-2-chloroacetylamino-2-deoxy-β-D-glucopyranosyl)-2-deoxy-3-O-(2,2,2-trichloro-tert-butoxycarbonyl)-2-(2,2,2-trichloro-tert-butoxycarbonylamino)-β-D-glucopyranoside 
• 111193-25-0 Allyl 4-O-benzyl-6-O-(3,4,6-tri-O-acetyl-2-chloroacetylamino-2-deoxy-β-D-glucopyranosyl)-2-deoxy-3-O-(2,2,2-trichloro-tert-butoxycarbonyl)-2-(2,2,2-trichloro-tert-butoxycarbonylamino)-α-D-glucopyranoside 
• 72894-35-0 propyl 2-acetamido-4,6-di-O-benzyl-2-deoxy-3-O-<3,4,6-tri-O-acetyl-2-(chloroacetamido)-2-deoxy-β-D-glucopyranosyl>-β-D-glucopyranoside 
• 98150-96-0 cyclohexyl 3,4,6-tri-O-acetyl-2-(chloroacetamido)-2-deoxy-β-D-glucopyranoside 
• 160242-92-2 5-(benzyloxycarbonylaminopentyl) 3,4,6-tri-O-acetyl-2-chloroacetamido-2-deoxy-β-D-glucopyranose 
• 160243-15-2 5-(benzyloxycarbonylamino)pentyl O-(3,4,6-tri-O-acetyl-2-chloroacetamido-2-deoxy-β-D-glucopyranosyl)-(1<*>3)-4-O-benzoyl-α-L-fucopyranoside 

Relevant articles and documents

GOLD COMPOSITIONS AND METHODS OF USE THEREOF

Gold compounds and pharmaceutically acceptable salts thereof are disclosed. Certain compounds and salts are active as antibacterial, antifungal, and/or anti-parasitic agents. The disclosure provides pharmaceutical compositions containing the gold compounds. Methods of using the gold compounds to treat bacterial infections are disclosed.

Efficient synthesis and enzymatic extension of an: N -GlcNAz asparagine building block

N-Azidoacetyl-d-glucosamine (GlcNAz) is a particularly useful tool in chemical biology as the azide is a metabolically stable yet accessible handle within biological systems. Herein, we report a practical synthesis of FmocAsn(N-Ac3GlcNAz)OH, a building block for solid phase peptide synthesis (SPPS). Protecting group manipulations are minimised by taking advantage of the inherent chemoselectivity of phosphine-mediated azide reduction, and the resulting glycosyl amine is employed directly in the opening of Fmoc protected aspartic anhydride. We show potential application of the building block by establishing it as a substrate for enzymatic glycan extension using sugar oxazolines of varying size and biological significance with several endo-β-N-acetylglucosaminidases (ENGases). The added steric bulk resulting from incorporation of the azide is shown to have no or a minor impact on the yield of enzymatic glycan extension.

The synthesis of new fluorinated or nonfluorinated sugar phosphonates and phosphoramidates as building blocks in the synthesis of modified hyaluronic acid subunits

The synthesis of several new fluorinated or nonfluorinated sugar phosphonates and phosphoramidates as building blocks for the synthesis of modified hyaluronic acid subunits is described. These compounds were prepared from d-glucose and d-glucosamine hydro